REATA PHARMACEUTICALS INC's ticker is RETA and the CUSIP is 75615P103. A total of 189 filers reported holding REATA PHARMACEUTICALS INC in Q3 2020. The put-call ratio across all filers is 0.71 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $611,000 | +8.1% | 3,917 | 0.0% | 0.04% | -11.6% |
| Q1 2020 | $565,000 | -29.5% | 3,917 | 0.0% | 0.04% | -6.5% |
| Q4 2019 | $801,000 | +155.1% | 3,917 | 0.0% | 0.05% | +130.0% |
| Q3 2019 | $314,000 | -15.1% | 3,917 | 0.0% | 0.02% | -20.0% |
| Q2 2019 | $370,000 | +10.4% | 3,917 | 0.0% | 0.02% | +19.0% |
| Q1 2019 | $335,000 | +52.3% | 3,917 | 0.0% | 0.02% | +31.2% |
| Q4 2018 | $220,000 | -31.2% | 3,917 | 0.0% | 0.02% | -30.4% |
| Q3 2018 | $320,000 | – | 3,917 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CPMG Inc | 3,063,567 | $298,453,000 | 49.63% |
| PARAGON ASSOCIATES & PARAGON ASSOCIATES II JOINT VENTURE | 150,000 | $14,613,000 | 19.62% |
| Corriente Advisors, LLC | 300,000 | $29,226,000 | 14.82% |
| Prosight Management, LP | 114,554 | $11,160,000 | 5.31% |
| MADDEN SECURITIES Corp | 43,927 | $4,279,000 | 3.18% |
| LBJ Family Wealth Advisors, Ltd. | 30,368 | $2,958,000 | 2.24% |
| Biondo Investment Advisors, LLC | 99,652 | $9,708,000 | 2.10% |
| Cormorant Asset Management, LP | 450,000 | $43,839,000 | 1.69% |
| Duquesne Family Office | 543,901 | $52,987,000 | 1.54% |
| AWH Capital, L.P. | 9,500 | $925,000 | 1.30% |